BCL2 and ovarian carcinoma: Possessed chemopreventive and chemotherapeutic effects against human ovarian cancer through the inhibition of β-catenin signaling pathway. It also inhibited the cell viability of A2780 ovarian cells in a dose-dependent manner, as well as induced apoptosis by the up-regulation of Bax and down-regulation of BCL-2.